- $25.01bn
- $46.75bn
- CA$20.01bn
- 77
- 57
- 72
- 77
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 14,589 | 15,341 | 16,838 | 18,292 | 20,005 |
Cost of Revenue | |||||
Gross Profit | 8,584 | 9,273 | 10,222 | 11,344 | 12,658 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 11,612 | 12,859 | 13,764 | 15,338 | 17,643 |
Operating Profit | 2,977 | 2,482 | 3,074 | 2,954 | 2,362 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2,244 | 1,711 | 2,278 | 2,322 | 1,089 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,776 | 1,260 | 1,698 | 1,718 | 867 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1,746 | 1,207 | 1,655 | 1,615 | 841 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,746 | 1,207 | 1,655 | 1,615 | 841 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.53 | 1.09 | 1.33 | 1.28 | 0.921 |
Dividends per Share |